Increased myristate acid levels can enhance AMPK signalling in ovarian cancer cells because of myristoylation of the AMPK β-subunit (AMPKβ is specifically regulated by NMT1 rather than NMT2). This evidence concerns the gene PRKAB1 and ovarian carcinoma.